Evolus
Price & Volume
Stats
See more52W Range | $3.86-$10.20 |
Market Cap | $435.2M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $301.7M |
Revenue Growth (YoY) | 6.7% |
Gross Profit (12 Mos) | $199.3M |
Diluted EPS | -$0.64 |
News
See moreYahoo Finance • 3 months ago
Revance CEO Nadeem Moiz on Expansion, Opportunities & Capitalization
Yahoo Finance • 3 months ago
Telix Appoints David Gill as Non-Executive Director
Yahoo Finance • 4 months ago
Evolus Sees Toxin Market Stabilizing, Evolysse Gaining Traction, Raises 2028 Revenue Targets at Conference
Yahoo Finance • 4 months ago
Evolus posts record rally after Q4 beat
About
CEO | Mr. David Moatazedi |
Address | 520 Newport Center Drive, Newport Beach, CA, United States, 92660 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 350 |